Theravance Biopharma Inc (TBPH)

Stockholders Equity

$289.71M

Quarterly · Period ending: · USD

TBPH logo

TBPH Stockholders Equity

Latest reported$289.71M
TBPH Quarterly Shareholders Equity (-$6.99M → $289.71M)
High-resolution chart · PNG

TBPH stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Theravance Biopharma Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
289,705,000
290,594,000
296,723,000
232,681,000
224,848,000
165,983,000
175,545,000
185,654,000
193,689,000
204,868,000
212,995,000
246,130,000
280,161,000
370,559,000
441,800,000
480,578,000
-349,809,000
-351,450,000
-338,573,000
-323,592,000
-300,374,000
-373,218,000
-303,751,000
-261,536,000
-202,336,000
-157,936,000
-223,840,000
-182,805,000
-137,224,000
-113,252,000
-51,589,000
-13,445,000
34,387,000
63,407,000
115,178,000
184,117,000
241,127,000
293,946,000
350,231,000
297,873,000
321,584,000
238,537,000
243,065,000
222,545,000
257,674,000
289,115,000
289,787,000
339,821,000
384,759,000
-17,916,000
-17,035,000
-14,367,000
-12,056,000
-4,375,000
-6,990,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.